tiprankstipranks
RepliCel Life Sciences Inc (REPCF)
OTHER OTC:REPCF
US Market
REPCF
RepliCel Life Sciences
RESEARCH TOOLSreports

RepliCel Life Sciences (REPCF) Financial Statements

23 Followers

RepliCel Life Sciences Financial Overview

RepliCel Life Sciences's market cap is currently $758.01K. The company's EPS TTM is $0.02; its P/E ratio is -9.38; RepliCel Life Sciences is scheduled to report earnings on August 19, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Dec 24Mar 24Mar 23Mar 22
Income Statement
Total RevenueC$ 353.44KC$ 353.74KC$ 353.74KC$ 353.74KC$ 353.74K
Gross ProfitC$ 0.00C$ 353.74KC$ 352.26KC$ 353.74KC$ 353.74K
Operating IncomeC$ 237.84KC$ -360.00KC$ -1.39MC$ -1.39MC$ -2.30M
EBITDAC$ 237.84KC$ -359.46KC$ -1.39MC$ -736.00KC$ -4.07M
Net IncomeC$ -401.63KC$ -97.29KC$ -312.00KC$ -743.00KC$ -4.07M
Balance Sheet
Cash & Short-Term InvestmentsC$ 5.52KC$ 1.81KC$ 76.41KC$ 430.27KC$ 238.44K
Total AssetsC$ 97.01KC$ 147.10KC$ 287.79KC$ 798.22KC$ 591.79K
Total DebtC$ 1.02MC$ 681.59KC$ 873.19KC$ 40.96KC$ 34.26K
Net DebtC$ 1.02MC$ 679.78KC$ 814.03KC$ -372.07KC$ -186.93K
Total LiabilitiesC$ 5.01MC$ 4.66MC$ 4.82MC$ 6.71MC$ 7.43M
Stockholders' EquityC$ -4.91MC$ -4.51MC$ -4.53MC$ -5.92MC$ -6.84M
Cash Flow
Free Cash FlowC$ -296.08KC$ -530.86KC$ -1.41MC$ -1.41MC$ -2.51M
Operating Cash FlowC$ -296.08KC$ -530.86KC$ -1.41MC$ -1.41MC$ -2.51M
Investing Cash FlowC$ 0.00C$ 17.25KC$ 0.00C$ 0.00C$ 0.00
Financing Cash FlowC$ 299.80KC$ 456.25KC$ 1.06MC$ 1.60MC$ 2.70M
Currency in CAD

RepliCel Life Sciences Earnings and Revenue History

Income Statement >

RepliCel Life Sciences Debt to Assets

Balance Sheet >

RepliCel Life Sciences Cash Flow

Cash Flow >

RepliCel Life Sciences Forecast EPS vs Actual EPS

Earnings >